To this end, we show, with our newly developed assay that detects synapse formation, that rapid antidepressant treatment in conjunction with GABABR activity promotes synaptogenesis in vitro and in vivo in WT animals, but not in a preclinical model of FXS (Fmr1 KO mouse). This evidence concerns the gene FMR1 and fragile X syndrome.